In acute stroke randomized trials, missingness of final functional outcome data reduces study power and potentially biases findings of treatment effect. Best methods for handling missing outcome data have not been well delineated for diseases with monophasic onset and subsequent improvement, like acute stroke.

Read More...

Leave a comment.

Your email address will not be published. Required fields are marked*

Andoird App
Loading...